← Back to Search

Behavioral Intervention

NOLA GEM App for HIV/AIDS

N/A

Waitlist Available

Research Sponsored by Tulane University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

* Having a reported HIV infection and being on ART.

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 90 days post assessment

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to create a smartphone app to help people living with HIV who have experienced violence, manage their health through understanding their daily experiences.

Who is the study for?

This trial is for people living with HIV who are currently on antiretroviral therapy (ART). It aims to help those affected by violence and dealing with substance use or mental health issues. Participants will need to be comfortable using a smartphone app as part of the study.

What is being tested?

The NOLA GEM trial is testing a new mobile app designed to support individuals with HIV. The app uses geographical ecological momentary assessment (GEMA) to track daily activities and psychosocial experiences, aiming to improve adherence to treatment and overall health outcomes.

What are the potential side effects?

Since this intervention involves the use of a smartphone app rather than medication, traditional side effects are not expected. However, participants may experience stress or emotional discomfort when reflecting on their daily experiences related to violence, substance use, or mental health.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 90 days post assessment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~90 days post assessment

This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days post assessment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Acceptability of intervention

Adherence

Care Engagement

+2 more

Secondary study objectives

Coping

Depression, anxiety

PTSD

+2 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

This arm will include daily diary assessment and GPS phone tracking, access to psychoeducational modules, skills practice, and tools to help with coping and stress reduction. Enhancements include geofencing alerts for risky environments; progress tracking and feedback reports; self-initiated tool engagement (e.g. push button to engage in coping exercise), robust JITAI programming that recommends skills for participants to use in the moment based on daily diary responses, positive mood building exercises, and support.

Group II: GEMAActive Control1 Intervention

This arm will include daily diary and phone tracking. Participants in this arm will also respond to daily diary assessments twice daily but will not receive the psychoeducation interactive components such as tracking and feedback, alerts, or capacity to send alerts that connect them to tools. This arm will have access to resources.

0 / 1Eligibility criteria met